# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-046730
Filing Date
2024-11-08
Accepted
2024-11-08 17:04:56
Documents
58
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cpix-20240930.htm iXBRL | 10-Q | 887432
2 | EX-31.1 | a2024q3-exhibit311.htm | EX-31.1 | 12676
3 | EX-31.2 | a2024q3-exhibit312.htm | EX-31.2 | 12669
4 | EX-32.1 | a2024q3-exhibit321.htm | EX-32.1 | 6882
| Complete submission text file | 0001628280-24-046730.txt |  | 4486765

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cpix-20240930.xsd | EX-101.SCH | 31766
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cpix-20240930_cal.xml | EX-101.CAL | 53815
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cpix-20240930_def.xml | EX-101.DEF | 113225
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cpix-20240930_lab.xml | EX-101.LAB | 435825
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cpix-20240930_pre.xml | EX-101.PRE | 293433
60 | EXTRACTED XBRL INSTANCE DOCUMENT | cpix-20240930_htm.xml | XML | 480283

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 241441662
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)